Company profile

Delfina

Chronic Disease Management & Digital Therapeutics

Company profile

About Delfina

Delfina is a maternal health technology company addressing the maternal health crisis in the United States through its integrated pregnancy data platform, Delfina Care. The company delivers personalized pregnancy care based on deep insights into each member's needs, combining AI-driven risk identification with high-touch, culturally competent support. Delfina's platform enables care teams to automate routine tasks and activate proactive care pathways to prevent complications, while pregnant members receive access to education, continuous doula support, telehealth services, and at-home monitoring through an engaging mobile app. The company serves healthcare providers, health plans, and employers nationwide, offering equitable access to pregnancy care across diverse populations. Delfina's high-risk care pathways are designed to reduce complications in pregnancy and birth, with the company guaranteeing same-year minimum ROI for health plan partners. The platform provides data for quality improvement reporting including HEDIS, NCQA, and CMS measures, and has achieved an 83.3 NPS score with a 5-star app store rating. Founded by doctors for doctors, Delfina partners with organizations including the National Association of Community Health Centers (NACHC) and Mayo Clinic to expand access to proactive maternal health support, particularly for communities facing the greatest barriers to healthcare access.

Company description Delfina official website

Primary marketChronic Disease Management & Digital Therapeutics
Commercial modelCommercial information available on request
Company presenceOfficial website
Work at Delfina?

Claim this profile to manage Company information and connect with the Health AI Central audience.

Claim this listing

01 · Operating footprint

Where the Company operates

Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.

Clinical focus

  • high-risk pregnancy
  • maternal metabolic health
  • preeclampsia
  • pregnancy complications

Who it serves

  • Community Health Centers
  • Employers
  • Health Plans
  • Healthcare Providers
  • OBGYNs

Deployment & integration

Cloud Saas deployment with recorded integration context.

Geographic context

MarketsCalifornia · Texas · United States
Company sourceOfficial website

Company milestones

Platform expansion

Selected for inaugural NACHC Accelerator 2026 cohort (March 2026). Partnership with Mayo Clinic announced for personalized metabolic health program. Transforming pregnancy care in California initiative. Partnership with NACHC to support community clinics across the country.

Partnerships

Recorded partners

  • California Surgeon General Dr. Diana Ramos
  • Community Health Centers nationwide
  • Mayo Clinic
  • National Association of Community Health Centers (NACHC)
  • ScaleHealth

02 · Flagship portfolio

Products, workflows, and platform capabilities

Selected source-backed Company products and the available commercial context.

Delfina Care

Integrated pregnancy platform delivering personalized care based on deep insights into each member's needs

Platform · Cloud SaaSCompany source

Delfina Member App

Mobile app providing pregnant members with education, doula support, telehealth, and at-home monitoring

Software · Cloud SaaSCompany source

03 · Research intelligence

Research Intelligence evidence

Publications, preprints, clinical validation, and regulatory records in Evidence Position order.

Evidence position

Publications, clinical validation, and regulatory records connected to this Company appear here.

Research

Publications & preprints

Wildlife forensic DNA evidence links a suspected vehicle to a fatal lowland tapir (Tapirus terrestris) collision in Misiones, Argentina.

Science & justice : journal of the Forensic Science Society · Sep 1, 2026

Convergence and divergence of mental health symptoms among adolescents and their friends.

European child & adolescent psychiatry · Aug 24, 2026

Self-medication with herbal remedies and pharmaceuticals for COVID-19 among healthcare students in Maputo.

Scientific reports · Jun 16, 2026

Childhood trauma assessed using the childhood trauma questionnaire and its influence on pediatric mood disorders and self-harm: a systematic review and meta-analysis.

Child abuse & neglect · May 1, 2026

Uncovering the diversity of microalgal harmful species in Chile through multidisciplinary characterization.

Marine pollution bulletin · Apr 1, 2026

Science diplomacy, research and global health.

Nature microbiology · Apr 1, 2026

Clinical validation

Clinical-trial records

Youth Suicide Risk Factors, Reduction of Suicide Risk Factor in Youth People

NCT07188506 · Mentioned · RECRUITING

Empirical Meropenem Dosing in Critically Ill Patients: Early Assessment of Plasma Exposure and Minimum Inhibitory Concentration Targets

NCT07681544 · Mentioned · COMPLETED

A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have Not Taken Biologic Medicines

NCT06671483 · Mentioned · RECRUITING

A Study to Evaluate the Drug Levels, Efficacy and Safety of Deucravacitinib in Children and Adolescent Participants With Moderate to Severe Plaque Psoriasis

NCT04772079 · Mentioned · RECRUITING

Effect of Spinae Erector Block (ESP) and Gabapentin on Recovery and Length of Stay in Adolescent Spinal Fusion Patients

NCT06096480 · Mentioned · UNKNOWN

Supplementation With Alpha-lipoic Acid and Silybum Marianum(LUDLEV®) for the Improvement of Fatty Liver Disease

NCT05913986 · Mentioned · UNKNOWN

Regulatory

Regulatory records

No linked records are currently available.

04 · Company-reported outcomes

Outcomes and case studies

Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.

NPS Score 83.3

Member satisfaction as of 6/30/24

5-star app store rating

Mobile app user satisfaction

Beat national average on high-cost conditions

Maternal health complications and interventions

Same-year minimum ROI

Guaranteed for health plan partners

California State Government

Transforming pregnancy care in California with partnership involving California Surgeon General Dr. Diana Ramos

Transforming pregnancy care delivery across California

National Association of Community Health Centers (NACHC)

Supporting community health centers across the country to improve maternal health outcomes for underserved populations

Selected for inaugural NACHC Accelerator 2026 cohort to expand proactive maternal health innovation to more communities nationwide

Health Plan (unnamed)

Closing the loop with providers between appointments and helping members know when to seek extra support

Members now have a way to communicate with providers between appointments

Mayo Clinic

Creating personalized metabolic health program for expecting mothers

Partnership to develop personalized metabolic health program

Provider (unnamed)

Managing preeclampsia case by enabling patient to share symptoms and blood pressure values

Delfina was instrumental in managing the preeclampsia case appropriately

05 · Leadership

Leadership team

Leadership profiles and professional links from the current Company record.

Senan Ebrahim

Chief Executive Officer

Isabel Fulcher

Chief Scientific Officer

LinkedIn

Ali Ebrahim

Chief Technology Officer

LinkedIn

Regan Theiler

Associate Chief Medical Officer

LinkedIn

Mary Parman

President, Delfina Medical Group

LinkedIn

Andy Hobbs

VP of Provider Partnerships

LinkedIn

Jessica Barra

VP of Clinical Innovation

06 · Company updates

Updates from Delfina

Recent articles published on Delfina's official website.

No Company updates are currently listed.

07 · HAIC coverage

Coverage and analysis

Health AI Central reporting that mentions this Company.

No HAIC coverage is currently linked to this Company.

08 · Official presence

Company sources and channels

Curated official destinations from the active Company record.

09 · Market pathway

Additional Companies in this Market

Other active Companies in the same market, selected alphabetically from the HAIC directory.

Market context

Chronic Disease Management & Digital Therapeutics

Companies using AI and digital health tools to help patients manage chronic conditions through digital therapeutics, gamified health management, and AI-powered coaching. Covers management of all chronic diseases including diabetes, hypertension, COPD, heart disease, and multi-condition platforms. Includes continuous glucose monitoring (CGM) systems with AI analytics and insulin optimization algorithms.

Explore the full market directory or compare this Company with additional active profiles.

View all Companies in this market

10 · Pro research

Coming soon

Expanded Company research is in development.

Health AI Central Pro · Coming Soon

Deeper Company research is coming soon.

Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.

ResearchEvidence analysis

Linked research, clinical, and regulatory source pathways.

CompanyTechnical context

Expanded product, deployment, integration, and partnership research.

MethodSource & review record

Record-level provenance and review context.

Coming Soon